Clinical trial
Typhoid Vi Vaccine Effectiveness in Hechi, Guangxi, China
NCT00131833 · International Vaccine Institute, Other · Completed
Key facts
| NCT number | NCT00131833 |
|---|---|
| Title | Typhoid Vi Vaccine Effectiveness in Hechi, Guangxi, China |
| Official title | Typhoid Vi Vaccine Effectiveness in a Population Older Than 5 Years of Age Living in an Endemic Area in Hechi, Guangxi, P.R. China: A Group-Randomized Controlled Demonstration Project |
| Lead sponsor | International Vaccine Institute, Other |
| Collaborators | Centers for Disease Control and Prevention U.S. Fed Hechi City Center for Disease Centrol Wellcome Trust University of Western Ontario, Canada |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Typhoid, Paratyphoid Fever |
| Intervention type | Biological |
| Interventions | Typhoid Vi vaccine, Meningococcal A (control) |
| Enrollment | 96,468 |
| Start date | Oct 1, 2001 |
| Primary completion | Nov 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Aug 19, 2005 |
| Last update posted | Mar 13, 2008 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: